Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Frontiers in Microbiology|November 5, 2019
Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and MechanismsJana L Jacobs, Elias K Halvas, Melissa A Tosiano, et al.Journal of Clinical Microbiology|November 8, 2005
Sensitive phenotypic detection of minor drug-resistant human immunodeficiency virus type 1 reverse transcriptase variantsDwight V Nissley, Elias K Halvas, Nicole L Hoppman, et al.Journal of Virological Methods|December 21, 2016
Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypesCarole L Wallis, Raquel V Viana, Shanmugam Saravanan, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
HIV-1 envelopes from virions that persist in plasma on antiretroviral therapy show reduced susceptibility to autologous immunoglobulins and variable sensitivity to broadly neutralizing monoclonal antibodiesSavrina Manhas, Joseph P Brooker, Cory Shetler, et al.Plos Pathogens|February 23, 2017
Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cellsJohn K Bui, Elias K Halvas, Elizabeth Fyne, et al.Proceedings of the National Academy of Sciences of the United States of America|April 19, 2017
Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ARTAnn Wiegand, Jonathan Spindler, Feiyu F Hong, et al.The Journal of Infectious Diseases|January 28, 2010
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patientsElias K Halvas, Ann Wiegand, Valerie F Boltz, et al.Journal of Virology|June 8, 2022
Deep Sequencing Analysis of Individual HIV-1 Proviruses Reveals Frequent Asymmetric Long Terminal RepeatsKevin W Joseph, Elias K Halvas, Leah D Brandt, et al.The Journal of Infectious Diseases|January 21, 2014
Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVPValerie F Boltz, Yajing Bao, Shahin Lockman, et al.AIDS (London, England)|March 4, 2006
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapySarah Palmer, Valerie Boltz, Frank Maldarelli, et al.Pageof 4